Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review

References

• HalbreichUThe diagnosis of premenstrual syndromes and premenstrual dysphoric disorder clinical procedures and research perspectivesGynecol Endocrinol200419632032415724807
   PubMed Web of Science ®Google Scholar
• HylanTRSundellKJudgeRThe impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and FranceJ Womens Health Gend Based Med1999881043105210565662
   PubMed Web of Science ®Google Scholar
• CampbellEMPeterkinDO’GradyKSanson-FisherRPremenstrual symptoms in general practice patients. Prevalence and treatmentJ Reprod Med199742106376469350019
   PubMed Web of Science ®Google Scholar
• WittchenHUBeckerELiebRKrausePPrevalence, incidence and stability of premenstrual dysphoric disorder in the communityPsychol Med2002320111913211883723
   PubMed Web of Science ®Google Scholar
• World Health OrganizationMental, behavioural and developmental disordersTenth Revision of the International Classification of Diseases (ICD-10)GenevaWorld Health Organization1966
   Google Scholar
• HalbreichUBackstromTErikssonEClinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studiesGynecol Endocrinol200723312313017454164
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)ArlingtonAmerican Psychiatric Association2013
   Google Scholar
• SteinerMMacdougallMBrownEThe premenstrual symptoms screening tool (PSST) for cliniciansArch Womens Ment Health20036320323912920618
   PubMedGoogle Scholar
• ImaiAIchigoSMatsunamiKTakagiHPremenstrual syndrome: management and pathophysiologyClin Exp Obstet Gynecol2014422123128
   Web of Science ®Google Scholar
• SchmidtPJNiemanLKDanaceauMAAdamsLFRubinowDRDifferential behavioral effects of gonadal steroids in women with and in those without premenstrual syndromeN Engl J Med199833842092169435325
   PubMed Web of Science ®Google Scholar
• AndréenLNybergSTurkmenSvan WingenGFernándezGBäckströmTSex steroids induced negative mood may be explained by the paradoxical effect mediated by GABA modulatorsPsychoneuroendocrinology20093481121113219272715
   PubMed Web of Science ®Google Scholar
• FreemanEWLuteal phase administration of agents for the treatment of premenstrual dysphoric disorderCNS Drugs200418745346815139800
   PubMed Web of Science ®Google Scholar
• UsmanSABIndusekharRO’BrienSHormonal management of premenstrual syndromeBest Pract Res Clin Obstet Gynaecol200822225126017761457
   PubMed Web of Science ®Google Scholar
• RapkinAJMorganMGoldmanLBrannDWSimoneDMaheshVBProgesterone metabolite allopregnanolone in women with premenstrual syndromeObstet Gynecol19979057097149351749
   PubMed Web of Science ®Google Scholar
• ProtopopescuXTuescherOPanHToward a functional neuroanatomy of premenstrual dysphoric disorderJ Affect Disord20081081879418031826
   PubMed Web of Science ®Google Scholar
• FreedmanEWPremenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosisPsychoneuroendocrinology200328252712892988
   PubMed Web of Science ®Google Scholar
• DueñasJLLeteIBermejoRPrevalence of premenstrual syndrome and premenstrual dysphoric disorder in a representative cohort of Spanish women of fertile ageEur J Obstet Gynecol Reprod Biol20111561727721227566
   PubMed Web of Science ®Google Scholar
• AdewuyaAOLotoOMAdewumiTAPattern and correlates of premenstrual symptomatology amongst Nigerian university studentsJ Psychosom Obstet Gynecol2009302127132
   PubMed Web of Science ®Google Scholar
• BorensteinJEDeanBBEndicottJHealth and economic impact of the premenstrual syndromeJ Reprod Med200348751552412953326
   PubMed Web of Science ®Google Scholar
• LeteIDueñasJLSerranoIAttitudes of Spanish women toward premenstrual symptoms, premenstrual syndrome and premenstrual dysphoric disorder: results of a nationwide surveyEur J Obstet Gynecol Reprod Biol2011159111511821775045
   PubMed Web of Science ®Google Scholar
• MarjoribanksJBrownJO’BrienPMWyattKSelective serotonin reuptake inhibitors for premenstrual syndromeCochrane Database Syst Rev20136CD001396
   PubMed Web of Science ®Google Scholar
• ShahNRJonesJBAperiJShemtovRKarneABorensteinJSelective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysisObstet Gynecol20081115117518448752
   PubMed Web of Science ®Google Scholar
• KaurGGonsalvesLThackerHLPremenstrual dysphoric disorder: a review for the treating practitionerCleve Clin J Med200471430332115117171
   PubMed Web of Science ®Google Scholar
• WangMHammarbäckSLindheBÅBäckströmTTreatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled studyAct Obstet Gynecol Scand19957410803808
   PubMed Web of Science ®Google Scholar
• FordOLethabyAMolBRobertsHProgesterone for premenstrual syndromeCochrane Database Syst Rev20123CD00341522419287
   PubMed Web of Science ®Google Scholar
• O’BrienSRapkinADennersteinLNevatteTDiagnosis and management of premenstrual disordersBMJ2011342d299421642323
   PubMed Web of Science ®Google Scholar
• WhiteARA review of controlled trials of acupuncture for women’s reproductive health careJ Fam Plann Reprod Health Care200329423323614662058
   PubMedGoogle Scholar
• LochEGSelleHBoblitzNTreatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castusJ Womens Health Gend Based Med20009331532010787228
   PubMedGoogle Scholar
• YakirMKreitlerSBrzezinskiAVithoulkasGOberbaumMBent-wichZEffects of homeopathic treatment in women with premenstrual syndrome: a pilot studyBr Homeopath J200190314815311479782
   PubMedGoogle Scholar
• NevatteTO’BrienPMSBäckströmTISPMD consensus on the management of premenstrual disordersArch Womens Ment Health201316427929123624686
   PubMed Web of Science ®Google Scholar
• JoffeHCohenLSHarlowBLImpact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deteriorationAm J Obstet Gynecol200318961523153014710055
   PubMed Web of Science ®Google Scholar
• RossCColemanGStojanovskaCFactor structure of the modified Moos Menstrual Distress Questionnaire: assessment of prospectively reported follicular, menstrual and premenstrual symptomatologyJ Psychosom Obstet Gynaecol200324316317414584303
   PubMed Web of Science ®Google Scholar
• ArcherDFLasaILTailoring combination oral contraceptives to the individual womanJ Womens Health (Larchmt)201120687989121631372
   PubMed Web of Science ®Google Scholar
• MonteleonePLuisiSTonettiAAllopregnanolone concentrations and premenstrual syndromeEur J Endocrinol2000142326927310700721
   PubMed Web of Science ®Google Scholar
• BreechLLBravermanPKSafety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorderInt J Womens Health2009185
   Google Scholar
• RapkinAJSorgerSNWinerSADrospirenone/ethinyl estradiolDrugs Today200844213314518389090
   PubMed Web of Science ®Google Scholar
• ParseyKSPongAAn open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogenContraception200061210511110802275
   PubMed Web of Science ®Google Scholar
• FreemanEWKrollRRapkinAEvaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorderJ Womens Health Gend Based Med200110656156911559453
   PubMedGoogle Scholar
• PearlsteinTBBachmannGAZacurHAYonkersKATreatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulationContraception200572641442116307962
   PubMed Web of Science ®Google Scholar
• YonkersKABrownCPearlsteinTBFoeghMSampson-LandersCRapkinAEfficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorderObstet Gynecol2005106349250116135578
   PubMed Web of Science ®Google Scholar
• LopezLMKapteinAAHelmerhorstFMOral contraceptives containing drospirenone for premenstrual syndromeCochrane Database Syst Rev20122CD00658622336820
   PubMed Web of Science ®Google Scholar
• FoidartJMWuttkeWBouwGMGerlingerCHeitheckerRA comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrelEur J Contracept Reprod Health Care20005212413410943575
   PubMedGoogle Scholar
• KellySDaviesEFearnsSEffects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy womenClin Drug Investig2010305325336
   Web of Science ®Google Scholar
• WichianpitayaJTaneepanichskulSA comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptomsObstet Gynecol Int2013201348714323577032
   PubMedGoogle Scholar
• SulakPJScowRDPreeceCRiggsMWKuehlTJHormone withdrawal symptoms in oral contraceptive usersObstet Gynecol200095226126610674591
   PubMed Web of Science ®Google Scholar
• KlippingCDuijkersITrummerDMarrJSuppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimenContraception2008781162518555813
   PubMed Web of Science ®Google Scholar
• BitzerJBanal-SilaoMJAhrendtHJHormone withdrawal-associated symptoms with ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 µg/desogestrel 150 µg (21/7 regimen)Int J Womens Health2015750150926056491
   PubMed Web of Science ®Google Scholar
• HalbreichUFreemanEWRapkinAJContinuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorderContraception2012851192722067793
   PubMed Web of Science ®Google Scholar
• KwanIOnwudeJLPremenstrual syndromeBMJ Clin Evidence200912806
   Google Scholar
• FreemanEWHalbreichUGrubbGSAn overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndromeContraception201285543744522152588
   PubMed Web of Science ®Google Scholar
• HalbreichUMonacelliESome clues to the ethiology of premenstrual syndrome/premenstrual dysphoric disorderPrim psychiatry2004113340
   Google Scholar
• GuengerichFPMetabolism of 17 α-ethynylestradiol in humansLife Sci19904722198119882273938
   PubMed Web of Science ®Google Scholar
• LoboRAStanczykFZNew knowledge in the physiology of hormonal contraceptivesAm J Obstet Gynecol19941705149915078178898
   PubMed Web of Science ®Google Scholar
• MashchakCALoboRADozono-TakanoRComparison of pharmacodynamic properties of various estrogen formulationsAm J Obstet Gynecol198214455115186291391
   PubMed Web of Science ®Google Scholar
• DuijkersIJKlippingCGrobPKorverTEffects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiolEur J Contracept Reprod Health Care201015531432520695770
   PubMed Web of Science ®Google Scholar
• GerritsMGSchnabelPGPostTMPeetersPAPharmacokinetic profile of nomegestrol acetate and 17β-estradiol after multiple and single dosing in healthy womenContraception201387219320022898360
   PubMed Web of Science ®Google Scholar
• NappiRETerrenoESancesGEffect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM)Contraception201388336937523453784
   PubMed Web of Science ®Google Scholar
• WitjesHCreininMDSundström-PoromaaIMartin NguyenAKorverTComparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrheaEur J Contracept Reprod Health Care201520429630725712537
   PubMed Web of Science ®Google Scholar
• LeteIde la ViudaEPérez-CamposEEffect on quality of life of switching to combined oral contraception based on natural oestrogen: an observational, multicentre, prospective, phase 4 study (ZOCAL Study)Eur J Contracept Reprod Health Care201621427628427220697
   PubMed Web of Science ®Google Scholar